Accounting for assay performance when estimating the temporal dynamics in SARS-CoV-2 seroprevalence in the U.S
Description
Reconstructing the incidence of SARS-CoV-2 infection is central to understanding the state of the pandemic. Seroprevalence studies are often used to assess cumulative infections as they can identify asymptomatic infection. Since July 2020, commercial
